PFA Newspaper publication for publication of unaudited financial results as on 30.09.2025
Awaiting price reaction for this filing.
MPS Pharmaa Limited (formerly Advik Laboratories) submitted copies of newspaper clippings of its unaudited standalone financial results for the quarter and half year ended 30 September 2025, as required under SEBI LODR regulations. The results were published on 15 November 2025 in Financial Express (English) and Jansatta (Hindi). For Q2FY26, the company reported a net loss of Rs. 22.02 lakh, slightly better than Rs. 22.13 lakh in Q2FY25. For H1FY26, the net loss stood at Rs. 44.03 lakh. Loss per share for the quarter was Rs. 0.12 (unchanged from the year-ago quarter) and Rs. 0.23 for the half year. The results were approved by the board on 14 November 2025 after a limited review by statutory auditors.
The company continues to post quarterly losses with no meaningful improvement in profitability compared to last year. This is a routine regulatory compliance filing and is unlikely to move the stock, but sustained losses remain a concern for shareholders.